Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices 60873 

accommodate all requests, the ASC may 

refuse attendance on that reasonable 

basis. The use of any video or audio 

tape recording device, photographing 

device, or any other electronic or 

mechanical device designed for similar 

purposes is prohibited at ASC meetings. 

Dated: September 26, 2013. 

James R. Park, 

Executive Director. 

[FR Doc. 2013–23985 Filed 10–1–13; 8:45 am] 

BILLING CODE 6700–01–P 

FEDERAL FINANCIAL INSTITUTIONS 

EXAMINATION COUNCIL 

[Docket No. AS13–23] 

Appraisal Subcommittee Meeting 

AGENCY: Appraisal Subcommittee of the 

Federal Financial Institutions 

Examination Council. 

ACTION: Notice of meeting. 

SUMMARY: In accordance with Section 

1104(b) of Title XI of the Financial 

Institutions Reform, Recovery, and 

Enforcement Act of 1989, as amended, 

notice is hereby given that the Appraisal 

Subcommittee (ASC) will meet in closed 

session: 

DATES: October 9, 2013. 

ADDRESSES: 400 7th Street SW., 

Washington, DC 20024. 

SUPPLEMENTARY INFORMATION: 

Location: OCC—400 7th Street SW., 

Washington, DC 20024 

Date: October 9, 2013 

Time: Immediately following the ASC 

open session 

Status: Closed 

Matters To Be Considered 

September 11, 2013 minutes—Closed 

Session 

Preliminary discussion of State 

Compliance Reviews 

Dated: September 26, 2013. 

James R. Park, 

Executive Director. 

[FR Doc. 2013–23986 Filed 10–1–13; 8:45 am] 

BILLING CODE 6700–01–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

notices are set forth in paragraph 7 of 

the Act (12 U.S.C. 1817(j)(7)). 

The notices are available for 

immediate inspection at the Federal 

Reserve Bank indicated. The notices 

also will be available for inspection at 

the offices of the Board of Governors. 

Interested persons may express their 

views in writing to the Reserve Bank 

indicated for that notice or to the offices 

of the Board of Governors. Comments 

must be received not later than October 

16, 2013. 

A. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. Glory Burns, Fort Collins, Colorado, 

Robin Isham, Templeton, California, 

Andrea Voss, Chadron, Nebraska, Julie 

Jennings, Lone Tree, Colorado, and R. 

Will Isham, Gordon, Nebraska, 

individually and as trustees of the E. Joy 

Isham Irrevocable Trust, and the RWI 

Marital Deduction Testamentary Trust, 

both of Gordon, Nebraska, all as 

members of the Isham Family Group, to 

retain voting shares of Isham 

Management Company, and thereby 

indirectly retain voting shares of The 

First National Bank of Gordon, both in 

Gordon, Nebraska. 

Board of Governors of the Federal Reserve 

System, September 26, 2013. 

Margaret McCloskey Shanks, 

Deputy Secretary of the Board. 

[FR Doc. 2013–23936 Filed 10–1–13; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

has taken final action in the following 

case: 

Nitin Aggarwal, Ph.D., Medical 

College of Wisconsin and University of 

Wisconsin-Madison: Based on the 

reports of the investigations conducted 

by the Medical College of Wisconsin 

(MCW) and the University of 

Wisconsin-Madison (UW) and 

additional analysis conducted by the 

ORI in its oversight review, ORI found 

that Dr. Nitin Aggarwal, former 

Graduate Student, MCW, and former 

Assistant Scientist, UW, engaged in 

research misconduct in research 

supported by National Heart, Lung, and 

Blood Institute (NHLBI), National 

Institutes of Health (NIH), grants R01 

HL37981, R01 HL54075, and R01 

HL57414. 

ORI found that that the Respondent 

engaged in research misconduct by 

falsifying and/or fabricating PHSsupported data in six (6) figures that 

were included in the following two (2) 

publications, one (1) grant application 

to the American Heart Association 

(AHA), one (1) grant application to NIH, 

and the Respondent’s Ph.D. thesis: 

• Aggarwal, N.T., Pfister, S.L., & 

Campbell, W.B. ‘‘Hypercholesterolemia 

Enhances 15-Lipoxygenase Mediated 

Vasorelaxation and AcetylcholineInduced Hypotension.’’ Arteriosclerosis, 

Thrombosis, and Vascular Biology 

28:2209–2215, 2008 (hereafter the 

‘‘ATVB paper’’). 

• Aggarwal, N.T., Pfister, S.L., 

Gauthier, K.M., Chawengsub, Y., Baker, 

J.E., & Campbell, W.B. ‘‘Chronic hypoxia 

enhances 15-lipoxygenase-mediated 

vasorelaxation in rabbit arteries.’’ 

American Journal of Physiology—Heart 

Circulation Physiology 296:H678–H688, 

2008 (hereafter the ‘‘AJP paper’’). 

• Aggarwal, N.T., Principal 

Investigator (P.I.), National Scientist 

Development grant application to the 

American Heart Association No. 

11SDG7650072, ‘‘Sulfonylurea 

rReceptor-2 splice variant and 

mitochondrial mechanisms for 

cardioprotection and arrhythmia’’ 

(hereafter the ‘‘AHA grant application’’). 

• K99 HL113518–01, ‘‘Mitochondrial 

ATP-sensitive K-channels and 

pharmacological approaches for 

cardioprotection,’’ Aggarwal, Nitin, 

Ph.D., P.I. 

• Aggarwal, N.T. ‘‘Endothelial 15- 

lipoxygenase regulates vasorelaxation 

and blood pressure in rabbits in normal 

and pathological condictions.’’ A 

Dissertation Submitted to the Faculty of 

the Graduate School of Biomedical 

Science of the Medical College of 

Wisconsin in Partial Fulfillment of the 

Requirements for the Degree of Doctor of 

Philosophy, Milwaukee, Wisconsin, 

2008 (hereafter the ‘‘thesis’’). 

Specifically, ORI found that 

Respondent engaged in research 

misconduct by falsifying Western blot 

loading control data by inverting, 

duplicating, and cropping source blot 

films and/or using films from unrelated 

experiments to construct five (5) false 

Western blot figures. In the absence of 

valid blot images, Respondent falsified 

and/or fabricated the corresponding 

quantitative data for summary bar 

graphs and the data statistics in related 

text. Respondent admitted to falsely 

reporting the number of mice reported 

for an experiment reported in Figure 4 


tkelley on DSK3SPTVN1PROD with NOTICES